| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 140.363 | 117.618 | 121.405 | 127.686 | 177.897 | 250.205 | 271.103 | 308.021 | 314.329 | 323.317 |
| Total Income - EUR | 142.312 | 117.618 | 121.406 | 127.800 | 184.040 | 251.495 | 271.610 | 308.690 | 314.331 | 325.911 |
| Total Expenses - EUR | 141.926 | 117.196 | 121.316 | 124.741 | 175.013 | 239.655 | 264.503 | 300.433 | 309.930 | 324.800 |
| Gross Profit/Loss - EUR | 387 | 423 | 90 | 3.059 | 9.027 | 11.840 | 7.107 | 8.257 | 4.401 | 1.111 |
| Net Profit/Loss - EUR | 387 | 423 | -1.124 | 1.774 | 7.238 | 9.672 | 4.710 | 5.312 | 1.678 | 555 |
| Employees | 5 | 5 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Medifarm Speranta Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.042 | 612 | 204 | 0 | 0 |
| Current Assets | 72.257 | 71.834 | 49.103 | 45.345 | 73.377 | 106.474 | 115.288 | 112.393 | 122.810 | 122.357 |
| Inventories | 26.928 | 31.985 | 23.371 | 17.762 | 29.804 | 54.620 | 48.653 | 47.994 | 59.255 | 59.027 |
| Receivables | 31.925 | 32.802 | 22.477 | 23.898 | 31.702 | 44.387 | 50.803 | 61.867 | 59.679 | 60.865 |
| Cash | 13.405 | 7.047 | 3.255 | 3.685 | 11.871 | 7.467 | 15.832 | 2.531 | 3.877 | 2.465 |
| Shareholders Funds | 5.366 | 5.734 | 4.513 | 6.204 | 13.383 | 22.801 | 27.006 | 27.066 | 28.661 | 29.056 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 66.892 | 66.100 | 44.590 | 39.314 | 60.206 | 84.779 | 88.935 | 85.617 | 94.219 | 93.436 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Medifarm Speranta Srl